The government’s Rs 1,500 crore bet on Biological E’s vaccine candidate that is still undergoing trials may be a risk worth taking, experts said but an industry executive said the money should have been used to buy vaccines already in the marketIs the govt taking a risk on Bio E vaccine that#39;s yet to cross the finish line?
The government’s Rs 1,500 crore bet on Biological E’s vaccine candidate that is still undergoing trials may be a risk worth taking, experts said but an industry executive said the money should have been used to buy vaccines already in the market
Subscribe to:
Post Comments (Atom)
-
The company, one of the leading manufacturers of soda ash, had initiated the process of carving out its textiles business into GHCL Textile...
-
The BRLLR linked to RBI Repo Rate is revised downwards in line with the reduction on Reserve Bank of India Repo Rate from 5.15 percent to 4...
-
The company did not export units last month while it had dispatched 804 Etios units in in June 2019.
No comments:
Post a Comment